Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release - PubMed (original) (raw)

Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release

D A Knight et al. Am J Respir Cell Mol Biol. 1999 Apr.

Abstract

The distribution and regulation of leukemia inhibitory factor (LIF) and its receptor (LIFR) in human lung tissue is unknown. We recently found that LIF was immunolocalized to several cell types in human airways, and that exogenous LIF modulated neural and contractile responses of explanted airways. The present study aimed to determine the cellular distribution and regulation of gene transcripts for LIF and LIFR in human lung, and measured the release of LIF in response to anti-immunoglobulin (Ig)E, interleukin (IL)-1beta, and IL-6. Exposure of human lung to IL-1beta (100 pg/ml) resulted in the rapid induction of LIF messenger RNA (mRNA) (1 h) and subsequent protein release (6 h). Similar results were observed when lung tissue was exposed to anti-IgE (6 U/ml). Gene transcripts for LIF were observed in nine pulmonary cell types, with the greatest expression occurring in fibroblasts. LIFR transcripts were also widely expressed in these cell types. In cultures of nontransformed epithelial cells, lung fibroblasts, and airway smooth-muscle cells, IL-1beta (100 pg/ml) induced the rapid accumulation of LIF mRNA and protein release, with fibroblasts liberating the greatest amount. IL-6 also induced the expression of LIF mRNA and release of LIF in airway smooth-muscle cells, whereas exogenous LIF itself had no effect. Expression of LIFR mRNA was not influenced by exposure to IL-1beta or LIF in any of the cell lines used. These results highlight the widespread distribution and rapid release of LIF in human lung tissue and, in conjunction with our previous report, suggest that this cytokine may play an important role in lung inflammatory processes and neuroimmune interactions.

PubMed Disclaimer

Cited by

Expression and effects of cardiotrophin-1 (CT-1) in human airway smooth muscle cells.
Zhou D, Zheng X, Wang L, Stelmack G, Halayko AJ, Dorscheid D, Bai TR. Zhou D, et al. Br J Pharmacol. 2003 Dec;140(7):1237-44. doi: 10.1038/sj.bjp.0705562. Epub 2003 Nov 3. Br J Pharmacol. 2003. PMID: 14597603 Free PMC article.
Airway smooth muscle as an immunomodulatory cell.
Damera G, Tliba O, Panettieri RA Jr. Damera G, et al. Pulm Pharmacol Ther. 2009 Oct;22(5):353-9. doi: 10.1016/j.pupt.2008.12.006. Epub 2008 Dec 24. Pulm Pharmacol Ther. 2009. PMID: 19121407 Free PMC article. Review.
LIF upregulates expression of NK-1R in NHBE cells.
Hu CP, Feng JT, Tang YL, Zhu JQ, Lin MJ, Yu ME. Hu CP, et al. Mediators Inflamm. 2006;2006(5):84829. doi: 10.1155/MI/2006/84829. Mediators Inflamm. 2006. PMID: 17392578 Free PMC article.
Intranuclear crosstalk between extracellular regulated kinase1/2 and signal transducer and activator of transcription 3 regulates JEG-3 choriocarcinoma cell invasion and proliferation.
Morales-Prieto DM, Ospina-Prieto S, Chaiwangyen W, Weber M, Hölters S, Schleussner E, Fitzgerald JS, Markert UR. Morales-Prieto DM, et al. ScientificWorldJournal. 2013 Oct 30;2013:259845. doi: 10.1155/2013/259845. eCollection 2013. ScientificWorldJournal. 2013. PMID: 24288470 Free PMC article.
Leukaemia inhibitory factor (LIF) upregulates excitatory non-adrenergic non-cholinergic and maintains cholinergic neural function in tracheal explants.
Knight DA, D'Aprile AC, Spalding LJ, Goldie RG, Thompson PJ. Knight DA, et al. Br J Pharmacol. 2000 Jul;130(5):975-9. doi: 10.1038/sj.bjp.0703415. Br J Pharmacol. 2000. PMID: 10882380 Free PMC article.

Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release - PubMed (original) (raw)